• Explore /
  • Poster
  • / Survival analysis by tumor response of nivolumab treatment in previously treated advanced gastric cancer from the DELIVER trial (JACCRO GC-08).

Survival analysis by tumor response of nivolumab treatment in previously treated advanced gastric cancer from the DELIVER trial (JACCRO GC-08).

Abstract Poster

Authors

Yu Sunakawa

Yu Sunakawa

Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan

Yu Sunakawa , Yasuhiro Sakamoto , Ryohei Kawabata , Atsushi Ishiguro , Yusuke Akamaru , Yosuke Kito , Masazumi Takahashi , Jin Matsuyama , Hiroshi Yabusaki , Akitaka Makiyama , Takahisa Suzuki , Masahiro Tsuda , Hisateru Yasui , Jun Hihara , Atsushi Takeno , Eisuke Inoue , Wataru Ichikawa , Masashi Fujii

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

UMIN000030850

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4039)

DOI

10.1200/JCO.2023.41.16_suppl.4039

Abstract #

4039

Poster Bd #

360

Abstract Disclosures

Similar Posters

First Author: Yosuke Kito

First Author: Jean-Philippe Metges

First Author: Kohei Shitara

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Impact of adding nivolumab to first-line chemotherapy in patients with advanced gastric cancer.

Impact of adding nivolumab to first-line chemotherapy in patients with advanced gastric cancer.

First Author: Mai Utsumi